Literature DB >> 31353151

Intravascular Lithotripsy and Impella Support to Assist Complex LM Angioplasty.

Francesca Ristalli1, Silvia Maiani2, Alessio Mattesini2, Miroslava Stolcova2, Francesco Meucci2, Brunilda Hamiti2, Serafina Valente3, Carlo Di Mario2.   

Abstract

Coronary and peripheral calcifications are associated with increased procedural complexity and suboptimal results in both coronary and peripheral percutaneous interventions. Intravascular lithotripsy (IVL) has recently entered the clinical scenario as a new technology for plaque modification, with promising results. We present a case of high risk left main (LM) percutaneous coronary intervention (PCI), in which peripheral Shockwave IVL was used to facilitate the delivery of an Impella CP via a 14 F sheath and coronary IVL was used to prepare a very calcific left main bifurcation lesion before stent deployment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Year:  2019        PMID: 31353151     DOI: 10.1016/j.carrev.2019.06.014

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  3 in total

Review 1.  Role of Lithotripsy for Small Calcified Iliacs in the Era of Big Devices.

Authors:  Francesca Ristalli; Carlotta Sorini Dini; Miroslava Stolcova; Giulia Nardi; Serafina Valente; Francesco Meucci; Carlo Di Mario
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

2.  Changing paradigm for treatment of heavily calcified coronary artery disease. A complementary role of rotational atherectomy and intravascular lithotripsy with shockwave balloon: a case report.

Authors:  Shana Tehrani; Sudhir Rathore; Vinod Achan
Journal:  Eur Heart J Case Rep       Date:  2020-12-13

3.  Intravascular lithotripsy to treat an ostial left main coronary artery stenosis due to porcelain aorta in a patient with congenital high-density lipoprotein deficiency.

Authors:  Murat Çimci; Juan F Iglesias; Christoph Huber; Francois Mach; Marco Roffi
Journal:  Anatol J Cardiol       Date:  2020-11       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.